Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Brain Cancer News ••• Topics • Countries • U.S. States

Brain Metastases News Monitoring

Get by Email • RSS

Published on 01:45 GMT

'Promising' new PET agent for brain metastases put on FDA's Fast Track

A new imaging agent targeted at brain metastases has been granted the U.S. Food and Drug Administration’s Fast Track designation. RAD101, or 18F-RAD101, is a PET imaging agent used to differentiate recurrent brain metastases from treatment-related effects …

Source: Health Imaging - Neutral
Published on Jun 12, 2025

FDA Grants Fast Track Designation to RAD101 for Imaging of Brain Metastases

The FDA has granted fast track designation to RAD101, an investigational imaging agent, to differentiate between recurrent brain metastases and treatment-related effects in patients with cerebral metastases originating from various solid tumors, including …

Source: OncLive - Pending
Published on Jun 12, 2025

Rewrite Rare non-small cell lung cancer with brain metastases responds to amivantamab monotherapy this news headline ...

image: Figure 3: CNS disease response on amivantamab. MRI Brain at the time of pre-treatment (A(i–iv)), 6 months (B(i–iv)), 19 months (C(i–iv)) post-treatment demonstrating complete resolution of CNS disease at 6 months (B(i–iv)), and 19 months (C(i–iv)). …

Source: Bioengineer.org - Indeterminate
Published on Jun 11, 2025

FDA Grants Fast Track Designation to RAD101 for Imaging of Recurrent Brain Metastases

The FDA has granted fast track designation to Radiopharm Theranostics’ novel imaging agent, RAD101. This indication is for distinguishing between recurrent disease and treatment effects in brain metastases, including cases involving leptomeningeal disease. …

Source: Targeted Oncology - Pending
Published on Jun 11, 2025

Optimizing Treatment for Symptomatic Melanoma Brain Metastases

Treatment for symptomatic melanoma brain metastases remains challenging, with limited efficacy from current standard immunotherapies like anti–PD-1 and anti-CTLA4. However, targeted triplet regimens have shown greater promise than doublet regimens in the …

Source: Targeted Oncology - Pending
Published on Jun 11, 2025

Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain ...

SYDNEY, June 11, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on Jun 9, 2025

MEDSIR announces positive results from TUXEDO─3 trial of patritumab deruxtecan in patients with active brain metastases ...

MEDSIR, a leading international medical research company, announced the positive results of the TUXEDO-3 trial at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025. This phase II study funded by Daiichi Sankyo and Merck, known as MSD …

Source: Pharmabiz.com - Neutral
Published on 00:25 GMT

Immunotherapy Timing Does Not Significantly Affect Outcomes in ES-SCLC

The timing of immunotherapy initiation does not play a major role in survival outcomes in patients with extensive-stage small cell lung cancer (ES-SCLC), new research has found.1 The findings, which were presented in a poster session at the American …

Source: The American Journal of Managed Care - Neutral
Published on Jun 12, 2025

Telisotuzumab Vedotin Elicits Responses in c-MET–Overexpressing NSCLC, Regardless of Prior Therapy

Telisotuzumab vedotin-tllv (Emrelis) demonstrated durable responses in patients with c-MET–overexpressing, nonsquamous, EGFR-wildtype non–small cell lung cancer (NSCLC), regardless of whether they received prior treatment with a platinum-based therapy, …

Source: OncLive - Pending
Published on Jun 12, 2025

FDA Approves Ibtrozi For Adults With ROS1+ NSCLC

The FDA has approved Nuvation Bio Inc.’s Ibtrozi (taletrectinib) for the treatment of locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) in adults, according to a news release published yesterday. An investors call was held …

Source: Formulary Watch - Pending
Published on Jun 12, 2025

FDA Approves Ibtrozi for ROS1-Positive Lung Cancer

On June 11, the Food and Drug Administration approved Ibtrozi (taletrectinib) for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC). In two clinical trials, about 90% of patients not previously treated with this …

Source: Cancer Health - Pending
Published on Jun 12, 2025

Nuvation Scores First FDA Nod With Oral Lung Cancer Drug

The FDA approved Nuvation Bio’s oral ROS1 blocker taletrectinib, which will be sold as Ibtrozi. The approval, issued Wednesday, is for the drug’s use in non-small cell lung cancer. Ibtrozi is Nuvation’s first commercial product. Writing to investors on …

Source: BioSpace - Pending
Published on Jun 12, 2025

Obrixtamig Plus Topotecan Could Address a Second-Line Need in SCLC

Preliminary data for the combination of the novel DLL3/CD3 bispecific T-cell engager obrixtamig (BI 764532) and topotecan have demonstrated that this regimen could fill a treatment gap in the second-line setting and beyond for patients with relapsed…

Source: OncLive - Pending
Published on Jun 12, 2025

FDA clears Nuvation's first product Ibtrozi, for lung cancer

Nuvation Bio is set to launch its first commercial product after the FDA approved its ROS1 inhibitor Ibtrozi as a treatment for ROS1-positive non-small cell lung cancer (NSCLC). Chief executive David Hung – who formerly led Axovant and Medivation before …

Source: pharmaphorum - Neutral
Published on Jun 12, 2025

David Hung's Nuvation Bio wins FDA approval for Ibtrozi to challenge Pfizer, BMS and Roche in lung cancer field

Nine years after selling Medivation to Pfizer for $14 billion, David Hung, M.D., is going toe to toe with the New York drugmaker and two other pharma giants in a lung cancer field. Hung’s Nuvation Bio has won FDA approval for Ibtrozi, or taletrectinib, to …

Source: Fierce Pharma - Neutral
Published on Jun 12, 2025

FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging

The Food and Drug Administration (FDA) has issued a fast track designation for the 18F-RAD101 positron emission tomography (PET) imaging agent, which may help differentiate between treatment impacts on brain metastases and disease recurrence. Radiopharm …

Source: Diagnostic Imaging - Pending
Published on Jun 12, 2025

Gilead’s Trodelvy wins Korean coverage for breast cancer -- too late for some and still off-limits up front

It took two years, 100,000 signatures, and a wave of public pressure from patients and doctors. Now, Gilead Sciences’ Trodelvy (sacituzumab govitecan) is finally reimbursed in Korea for metastatic triple-negative breast cancer (TNBC). But for many, the …

Source: Korea Biomedical Review - Neutral
Published on Jun 11, 2025

FDA Approves Taletrectinib for ROS1+ Advanced NSCLC

The FDA has approved taletrectinib (Ibtrozi) for the treatment of patients with locally advanced or metastatic, ROS1-positive non–small cell lung cancer.1,2 The regulatory decision was supported by data from the phase 2 TRUST-1 (NCT04395677) and TRUST-II ( …

Source: OncLive - Pending
Published on Jun 11, 2025

Taletrectinib Approved for NSCLC

The FDA has approved taletrectinib (Ibtrozi, Nuvation Bio) for locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) in first- and later-line settings, regardless of prior ROS1 tyrosine kinase inhibitor (TKI) exposure. …

Source: Medscape - Neutral

18 days 22:43:29

Featured Releases

Got News to Share? · Submit · See All

Published on June 12, 2025 - 12:32 GMT

The End Brain Cancer Initiative Announces 2025 National Patient Disease Education Initiative and HOPE Award Recipient

The End Brain Cancer Initiative Announces 2025 National Patient Disease Education Initiative and HOPE Award Recipient REDMOND, WA, UNITED STATES, June 12, 2025 /⁨EINPresswire.com⁩/ -- FOR IMMEDIATE RELEASE Contact: Dellann Elliott Mydland, 425- …

Distribution channels: Chemical Industry, Culture, Society & Lifestyle ...
Published on June 11, 2025 - 20:30 GMT

Result of General Meeting

June 11, 2025 Biodexa Pharmaceuticals PLC Result of General Meeting Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Got news to share? Submit it now.

Load more brain cancer news or search news using your own keywords. There are 821,867,343 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Brain Cancer News by Country

Brain Cancer News by U.S. State

Brain Cancer News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on June 13, 2025 - 11:00 GMT

Boulder Crest Foundation's Hero’s Journey Story Challenge Honors PTG Day with Films of Hope and Healing

Winning films highlight real-life journeys from trauma to triumph, reframing the national conversation around mental health. BLUEMONT, VA, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- BOULDER CREST FOUNDATION ANNOUNCES WINNER OF HERO’S …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on June 13, 2025 - 11:00 GMT

THE FLORIDA ASSOCIATION OF HEALTHY START COALITIONS LAUNCHES NEW BRANDING AND WEBSITE

TALLAHASSEE, FL, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- The Florida Association of Healthy Start Coalitions (FAHSC) is excited to announce their rebranding with a new logo and website. Harnessing the power of over 30 years as a …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on June 13, 2025 - 11:00 GMT

G7 LEADERS URGED TO STRENGTHEN BRAIN HEALTH TO BOOST ECONOMIC GROWTH AND STABILIZE HEALTH COSTS

As the cost of brain conditions is expected to balloon to $16 trillion by 2030, G7 leaders and Canada are uniquely positioned to deliver solutions. CALGARY, ALBERTA, CANADA, June 13, 2025 /⁨EINPresswire.com⁩/ -- A growing international coalition …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 13, 2025 - 11:00 GMT

TravelingWiki Online Resource Database Now Covers the 10 Busiest US Airports; Expects to Cover 150 Airports by EOY

TravelingWiki Now Offers Free Resources in English, Spanish, French, German, Mandarin, Japanese, Hebrew, Arabic, Portuguese, Hindi, Twi, Vietnamese & Russian. DENVER, CO, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- TravelingWiki …

Distribution channels: Aviation & Aerospace Industry, Healthcare & Pharmaceuticals Industry ...
Published on June 13, 2025 - 10:57 GMT

A Közép-európai Egyetem csatlakozik a Simons Alapítvány úttörő ökológiai idegtudományi kutatásához

VIENNA, AUSTRIA, June 13, 2025 /⁨EINPresswire.com⁩/ -- A Közép-európai Egyetem (CEU) kutatói egy jelentős új nemzetközi kezdeményezéshez csatlakoznak, amelyet a Simons Alapítvány indított azzal a céllal, hogy megértsék, hogyan irányítják az agy …

Distribution channels: Healthcare & Pharmaceuticals Industry, IT Industry ...
Published on June 13, 2025 - 10:53 GMT

A Body-Mapping Study of Nail Technicians' Occupational Health and Lived Experiences

GA, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- There is a growing body of evidence on the occupational health experiences of nail technicians. While these studies are vital to work towards safe worksites, they may inadvertently reduce nail salons …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on June 13, 2025 - 10:53 GMT

Kanwarpreet Trehan Wins the 2025 Top Physiotherapist Award of ThreeBestRated® for Re-building Strength, Restoring Hope

ABBOTSFORD, BRITISH COLUMBIA, CANADA, June 13, 2025 /⁨EINPresswire.com⁩/ -- Physiotherapy has been around for ages and has been playing a vital role in enhancing one’s mobility. Even today, its popularity has been on an upward trajectory. As a plethora of …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 13, 2025 - 10:51 GMT

Global Weight Management Supplements Market Outlook 2025-2034: Key Drivers, Trends, and Growth Opportunities

The Business Research Company's Global Weight Management Supplements Market Outlook 2025-2034: Key Drivers, Trends, and Growth Opportunities LONDON, GREATER LONDON, UNITED KINGDOM, June 13, 2025 /⁨EINPresswire.com⁩/ -- The Business Research …

Distribution channels: Business & Economy, Consumer Goods ...
Published on June 13, 2025 - 09:36 GMT

Stellar Market Research examines the growth rate of the Hernia Mesh Devices Market during the forecast period 2025-2032

Hernia Mesh Devices Market was valued at USD 4.10 bn in 2024 and is expected to reach USD 5.70 bn by 2032, at a CAGR of 4.2% during the forecast period. ORLANDO, FL, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- The Global Hernia Mesh …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 13, 2025 - 08:00 GMT

Hospital Bill Negotiators Are Saving Americans Millions

As medical debt surges nationwide, Goodbill is delivering powerful hospital bill reductions for health share members. AUSTIN, TX, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- In a healthcare system where over 80% of medical bills contain …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...
Published on June 13, 2025 - 07:00 GMT

'Let It Out' Book Offers Breakthrough Approach to Emotional Healing and Connection

Powerful pathways to reclaim your emotional voice and deepen human connections HOLLYWOOD, FL, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- A revolutionary new book by PAIRS Foundation CEO Seth Eisenberg is breaking the silence around …

Distribution channels: Book Publishing Industry, Culture, Society & Lifestyle ...
Published on June 13, 2025 - 06:48 GMT

Here's why 27% of sporting dads shouldn't neglect their feet

LONDON, UNITED KINGDOM, June 13, 2025 /⁨EINPresswire.com⁩/ -- New research by active foot care specialists, The Feets, reveals that 27% of dads who play sport are neglecting their feet despite admitting that foot ailments account for the most …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on June 13, 2025 - 06:39 GMT

Global Telerobots Market: Key Trends, Market Share, Growth Drivers, And Forecast For 2025-2034

The Business Research Company’s Telerobots Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 13, 2025 /⁨EINPresswire.com⁩/ -- Substantial growth has been witnessed in the telerobots market …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 13, 2025 - 06:21 GMT

Esthetic Smile Dental Care Announces Affordable Dental Implant Options in Reseda, CA

New dental implant options combine expert care with budget-friendly pricing, making confident, healthy smiles more accessible than ever. RESEDA, CA, UNITED STATES, June 12, 2025 /⁨EINPresswire.com⁩/ -- Esthetic Smile Dental Care, a trusted name in …

Distribution channels: Business & Economy, Companies ...
Published on June 13, 2025 - 06:18 GMT

Dentistry At Its Finest Launches New Dental Implant Services with Advanced Technology in Costa Mesa

Discover cutting-edge dental implant solutions at Dentistry At Its Finest in Costa Mesa, offering lasting, natural-looking tooth replacement options. COSTA MESA, CA, UNITED STATES, June 12, 2025 /⁨EINPresswire.com⁩/ -- Dentistry At Its Finest, a …

Distribution channels: Business & Economy, Companies ...
Published on June 13, 2025 - 05:33 GMT

AI Expert Jason Duprat to Speak at NNBA 2025 on Applied AI for Nurse Entrepreneurs

CRNA and Business Consultant With 2,100+ Hours of AI Experience to Share "Simple Systems That Maintain Your Authentic Style LAS VEGAS, NV, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- Jason Duprat, MBA, MSA, APRN, CRNA, will present “ …

Distribution channels: Business & Economy, Education ...
Published on June 13, 2025 - 05:21 GMT

Southwest Houston Clinic Offers Specialized Women's Health Care Services

Benech Family Clinic -- (281) 909-0102 provides women's health services in Southwest Houston, TX, offering screenings and specialized care. SOUTHWEST HOUSTON, TX, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- Benech Family Clinic, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 13, 2025 - 05:17 GMT

Stafford, TX Clinic Provides Laboratory & Diagnostic Tests For Comprehensive Care

Benech Family Clinic -- (281) 909 0102 offers laboratory & diagnostic tests in Stafford, Houston, TX, providing screening and preventative care. STAFFORD, HOUSTON, TX, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- Benech Family Clinic, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 13, 2025 - 05:16 GMT

Missouri City, TX Clinic Provides Comprehensive Primary Care Services

Benech Family Clinic -- (281) 909 0102 offers primary care in Missouri City, TX, providing preventative health services and walk-in appointments. MISSOURI CITY, HOUSTON, TX, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- Benech Family Clinic …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 13, 2025 - 05:07 GMT

Two Middle Tennessee, ALL-APP Addiction Recovery Centers Receive Prestigious Telehealth Accreditation

The Joint Commission awards its “Gold Seal of Approval” to Nashville Addiction Clinic and Recovery Care of Columbia NASHVILLE, TN, UNITED STATES, June 13, 2025 /⁨EINPresswire.com⁩/ -- Two Tennessee addiction recovery centers are setting a gold …

Distribution channels: Companies, Culture, Society & Lifestyle ...